Search
forResearch 10 of 1000+
- Treatment Trial of Mangy One Humped-Camels (<i>Camelus dromedarius</i>) by <i>Aloe vera</i> Gel Leaves
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
- Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial
- Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial
- Trial Treatment of Androgenetic Alopecia with Oxidizing Agents (Inaba and Inaba 1984)
- Safety and biopsy outcomes of a topical treatment (SM04554) for male androgenetic alopecia (AGA): Results from a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial
- Hair growth efficacy and safety assessment of an ayurvedic leave-on treatment: a clinical trial
- Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia
- A multicentre placebo‐controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment
Community 10 of 1000+
- Clinical Trial: N-Acetyl-Cysteine for Treatment of AGA in Men
- Hair Regrowth Following a Wnt- and Follistatin- Containing Treatment: Safety and Efficacy in a First-in-Man Phase 1 Clinical Trial: Scientific, Peer-Reviewed Dermatology Article Indexed with MEDLINE/PubMed
- Update July 2025] Most Promising Hair Loss Treatments in Clinical Trials
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
- ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- TH07 by Triple Hair entering phase III trial
- Han Bio Aims for Phase 1 Clinical Trials in 2027 after successful hair growth in mice
Learn 10 of 54
- Minoxidil
- Bimatoprost
- Adenosine
- Caffeine
- Metformin
- Dutasteride
- Low Level Laser Therapy
- Verteporfin
- GT20029
- Tofacitinib